These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 19749010)
1. Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies. Zamagni C; Wirtz RM; De Iaco P; Rosati M; Veltrup E; Rosati F; Capizzi E; Cacciari N; Alboni C; Bernardi A; Massari F; Quercia S; D'Errico Grigioni A; Dietel M; Sehouli J; Denkert C; Martoni AA Endocr Relat Cancer; 2009 Dec; 16(4):1241-9. PubMed ID: 19749010 [TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue. Darb-Esfahani S; Wirtz RM; Sinn BV; Budczies J; Noske A; Weichert W; Faggad A; Scharff S; Sehouli J; Oskay-Ozcelik G; Zamagni C; De Iaco P; Martoni A; Dietel M; Denkert C Endocr Relat Cancer; 2009 Dec; 16(4):1229-39. PubMed ID: 19675076 [TBL] [Abstract][Full Text] [Related]
3. Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin. Komiyama S; Kurahashi T; Ishikawa M; Tanaka K; Komiyama M; Mikami M; Udagawa Y Oncol Rep; 2011 Apr; 25(4):1131-8. PubMed ID: 21249319 [TBL] [Abstract][Full Text] [Related]
4. RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy. Denkert C; Loibl S; Kronenwett R; Budczies J; von Törne C; Nekljudova V; Darb-Esfahani S; Solbach C; Sinn BV; Petry C; Müller BM; Hilfrich J; Altmann G; Staebler A; Roth C; Ataseven B; Kirchner T; Dietel M; Untch M; von Minckwitz G Ann Oncol; 2013 Mar; 24(3):632-9. PubMed ID: 23131391 [TBL] [Abstract][Full Text] [Related]
5. Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer? Ayhan A; Taskiran C; Yigit-Celik N; Bozdag G; Gultekin M; Usubutun A; Guler N; Yuce K Int J Gynecol Cancer; 2006; 16(2):484-9. PubMed ID: 16681715 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy. Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774 [TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of histological tumor regression (Böhm's score) in patients receiving neoadjuvant chemotherapy for high grade serous tubal & ovarian carcinoma. Rajkumar S; Polson A; Nath R; Lane G; Sayasneh A; Jakes A; Begum S; Mehra G Gynecol Oncol; 2018 Nov; 151(2):264-268. PubMed ID: 30197060 [TBL] [Abstract][Full Text] [Related]
8. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients. Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a hormone receptor-positive ovarian carcinoma subtype with a favourable prognosis by determination of progesterone receptor and oestrogen receptor 1 mRNA expression in formalin-fixed paraffin-embedded tissue. Sinn BV; Darb-Esfahani S; Wirtz RM; Budczies J; Sehouli J; Chekerov R; Dietel M; Denkert C Histopathology; 2011 Nov; 59(5):918-27. PubMed ID: 22092403 [TBL] [Abstract][Full Text] [Related]
10. Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer. Kujawa KA; Zembala-Nożyńska E; Cortez AJ; Kujawa T; Kupryjańczyk J; Lisowska KM Cells; 2020 Jan; 9(1):. PubMed ID: 31936272 [TBL] [Abstract][Full Text] [Related]
11. Predicting Response to Standard First-line Treatment in High-grade Serous Ovarian Carcinoma by Angiogenesis-related Genes. Mendiola M; Redondo A; Heredia-Soto V; Herranz J; Berjón A; Hernández A; Miguel-Martín M; Crespo R; Barriuso J; Cruz P; Yébenes L; Peláez-García A; Castelo B; DE Molina AR; Feliu J; Hardisson D Anticancer Res; 2018 Sep; 38(9):5393-5400. PubMed ID: 30194194 [TBL] [Abstract][Full Text] [Related]
12. Amplification of GNAS may be an independent, qualitative, and reproducible biomarker to predict progression-free survival in epithelial ovarian cancer. Tominaga E; Tsuda H; Arao T; Nishimura S; Takano M; Kataoka F; Nomura H; Hirasawa A; Aoki D; Nishio K Gynecol Oncol; 2010 Aug; 118(2):160-6. PubMed ID: 20537689 [TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy. Hartmann LC; Lu KH; Linette GP; Cliby WA; Kalli KR; Gershenson D; Bast RC; Stec J; Iartchouk N; Smith DI; Ross JS; Hoersch S; Shridhar V; Lillie J; Kaufmann SH; Clark EA; Damokosh AI Clin Cancer Res; 2005 Mar; 11(6):2149-55. PubMed ID: 15788660 [TBL] [Abstract][Full Text] [Related]
14. HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy. Miller KR; Patel JN; Zhang Q; Norris EJ; Symanowski J; Michener C; Sehouli J; Braicu I; Destephanis DD; Sutker AP; Jones W; Livasy CA; Biscotti C; Ganapathi RN; Tait DL; Ganapathi MK Gynecol Oncol; 2018 Apr; 149(1):155-162. PubMed ID: 29402501 [TBL] [Abstract][Full Text] [Related]
15. Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies. Petrillo M; Zannoni GF; Beltrame L; Martinelli E; DiFeo A; Paracchini L; Craparotta I; Mannarino L; Vizzielli G; Scambia G; D'Incalci M; Romualdi C; Marchini S Ann Oncol; 2016 Apr; 27(4):625-34. PubMed ID: 26782955 [TBL] [Abstract][Full Text] [Related]
16. Comparisons of the survival time of patients with ovarian cancer adopting post-operative chemotherapy by use of paclitaxel combined with carboplatin or nedaplatin. Gao H; Yuan L; Han Y World J Surg Oncol; 2016 Jun; 14(1):168. PubMed ID: 27341795 [TBL] [Abstract][Full Text] [Related]
17. Survivin expression as a prognostic factor in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy. Gąsowska-Bodnar A; Bodnar L; Dąbek A; Cichowicz M; Jerzak M; Cierniak S; Kozłowski W; Baranowski W Int J Gynecol Cancer; 2014 May; 24(4):687-96. PubMed ID: 24662134 [TBL] [Abstract][Full Text] [Related]
18. Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR Germany. Hilpert F; du Bois A; Greimel ER; Hedderich J; Krause G; Venhoff L; Loibl S; Pfisterer J Ann Oncol; 2007 Feb; 18(2):282-7. PubMed ID: 17082513 [TBL] [Abstract][Full Text] [Related]
19. Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens. Trédan O; Geay JF; Touzet S; Delva R; Weber B; Cretin J; Provencal J; Martin J; Stefani L; Pujade-Lauraine E; Freyer G; Ann Oncol; 2007 Feb; 18(2):256-62. PubMed ID: 17082510 [TBL] [Abstract][Full Text] [Related]
20. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation. Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]